Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
340.67 USD | -1.50% |
|
-2.06% | -7.65% |
Capitalization | 76.97B 65.82B 61.31B 57.02B 105B 6,604B 117B 735B 281B 3,092B 289B 283B 11,342B | P/E ratio 2025 * |
11.1x | P/E ratio 2026 * | 9.18x |
---|---|---|---|---|---|
Enterprise value | 97.34B 83.24B 77.53B 72.11B 133B 8,352B 148B 929B 355B 3,911B 365B 358B 14,345B | EV / Sales 2025 * |
0.5x | EV / Sales 2026 * | 0.46x |
Free-Float |
99.81% | Yield 2025 * |
2.01% | Yield 2026 * | 2.15% |
More valuation ratios
* Estimated data
More news
Last Transcript: Elevance Health, Inc.
More recommendations
More press releases
More news
1 day | -1.50% | ||
1 week | -2.06% | ||
Current month | -12.42% | ||
1 month | -11.79% | ||
3 months | -22.54% | ||
6 months | -10.62% | ||
Current year | -7.65% |
1 week | 337.61 | ![]() | 350.68 |
1 month | 337.61 | ![]() | 400.53 |
Current year | 337.61 | ![]() | 458.75 |
1 year | 337.61 | ![]() | 567.26 |
3 years | 337.61 | ![]() | 567.26 |
5 years | 244.1 | ![]() | 567.26 |
10 years | 114.85 | ![]() | 567.26 |
Manager | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 64 | 2017-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 46 | 2023-10-31 |
Dustin Wilcox
CTO | Chief Tech/Sci/R&D Officer | - | 2018-07-31 |
Director | Title | Age | Since |
---|---|---|---|
Ramiro Peru
BRD | Director/Board Member | 69 | 2004-11-29 |
Robert Dixon
BRD | Director/Board Member | 69 | 2011-06-30 |
Lewis Hay
BRD | Director/Board Member | 69 | 2013-06-30 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
3.22% | 21 M€ | +4.23% | - | |
2.07% | 6 M€ | 0.00% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.50% | -2.06% | -36.39% | -28.73% | 76.97B | ||
+1.53% | -1.44% | -40.55% | -40.88% | 276B | ||
-1.78% | -5.15% | -9.41% | +8.56% | 81.02B | ||
-0.65% | -3.76% | -39.65% | -52.26% | 27.84B | ||
-3.32% | -5.61% | -53.67% | -63.82% | 15.64B | ||
-3.08% | -7.53% | -24.48% | -22.37% | 12.01B | ||
-0.07% | -1.47% | +50.73% | -3.05% | 2.65B | ||
-1.69% | +8.15% | -19.83% | -21.93% | 1.99B | ||
-4.26% | +14.06% | +93.38% | +16.80% | 1.49B | ||
-2.90% | +7.78% | +2.65% | - | 467M | ||
Average | -1.77% | +1.17% | -7.72% | -23.08% | 49.59B | |
Weighted average by Cap. | +0.09% | -2.00% | -33.78% | -31.37% |
2025 * | 2026 * | |
---|---|---|
Net sales | 195B 166B 155B 144B 267B 16,706B 296B 1,858B 710B 7,822B 730B 715B 28,692B | 209B 178B 166B 155B 286B 17,899B 317B 1,991B 761B 8,381B 782B 766B 30,741B |
Net income | 6.9B 5.9B 5.5B 5.11B 9.45B 592B 10.5B 65.88B 25.19B 277B 25.89B 25.36B 1,017B | 8.17B 6.99B 6.51B 6.05B 11.18B 701B 12.43B 77.98B 29.81B 328B 30.64B 30.01B 1,204B |
Net Debt | 20.38B 17.42B 16.23B 15.09B 27.89B 1,748B 31B 194B 74.35B 819B 76.42B 74.84B 3,003B | 19.05B 16.29B 15.17B 14.11B 26.08B 1,634B 28.98B 182B 69.51B 765B 71.44B 69.97B 2,807B |
More financial data
* Estimated data
Employees
104,200
Sector
Managed Healthcare
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-07-11 | 340.67 $ | -1.50% | 1,698,417 |
25-07-10 | 345.86 $ | -0.14% | 2,218,484 |
25-07-09 | 346.36 $ | -0.89% | 1,822,210 |
25-07-08 | 349.46 $ | +0.74% | 1,619,591 |
25-07-07 | 346.88 $ | -0.28% | 2,256,047 |
Delayed Quote Nyse, July 11, 2025 at 04:00 pm
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
22
Last Close Price
340.67USD
Average target price
494.60USD
Spread / Average Target
+45.18%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELV Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition